TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
XNCR

Xencor Inc

Healthcare · Biotechnology

25.20$ +0.5% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

Xencor Inc (XNCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 51 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement XNCR
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
59 51 16 17 18 70 33 44 21 28 4.5 51 105
65 3.2 57 3.0 58 51 2.7 2.7 54 2.6 2.6
-5.8 48 -41 14 -40 70 30 41 -33 26 1.9 51 45
65 63 57 62 58 51 59 62 54 65 65 72 256
12 15 14 18 15 15 17 15 14 17 18 16 65
12 76 14 76 15 66 73 74 14 79 80 88 262
-18 -29 -55 -62 -55 4.0 -43 -33 -48 -54 -78 -37 -216
0.0 6.2 9.7 0.8 0.8 34 8.7 8.2 7.7 7.4 4.7 7.4 27
-24 -13 -74 -67 -47 -53 -48 -31 -6.0 -4.3 -129 -22 -161
-3.1 14 -0.7 0.1 -1.2 1.5 0.4 -0.3 2.4 0.3 -0.2
-24 -26 -73 -66 -46 -53 -48 -31 -6.0 -6.7 -129 -22 -163
-21 -3.2 -61 -63 -35 -16 -37 -20 4.2 5.7 -121 -12 -124

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?